Evidence map›Paper›PMID 34364072›Full record

ArticleClinical imaging2021

A case of secondary sclerosing cholangitis due to COVID-19.

Shima Tafreshi, Ian Whiteside, Irving Levine, Catherine D'Agostino

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Observational
  4. Post-COVID-19 cholangiopathy: Systematic review.World journal of methodology · 2023
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Coronavirus Disease in the Abdomen.Advances in clinical radiology · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shima TafreshiNSLIJ Northwell Health System, Department of Radiology, 300 Community Drive, Manhasset, NY 11030, United States. Electronic address: stafreshi1@northwell.edu.
Ian WhitesideNSUH Northwell Health System, Department of Radiology, 300 Community Drive, Manhasset, NY 11030, United States. Electronic address: iwhiteside@northwell.edu.
Irving LevineNSUH Northwell Health System, 300 Community Drive, Manhasset, NY 11030, United States. Electronic address: ilevine2@northwell.edu.
Catherine D'AgostinoNSUH Northwell Health System, Department of Radiology, 300 Community Drive, Manhasset, NY 11030, United States. Electronic address: cdagostino@northwell.edu.
Northwell Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 was first recognized by the World Health Organization (WHO) in December 2019 and declared a global pandemic in March 2020. Although COVID-19 primarily results in pulmonary symptoms, it is becoming apparent that it can lead to multisystemic manifestations. Liver damage with elevated AST and ALT is seen in patients with COVID-19. Although the etiology of liver damage is still debated, biliary damage is rarely seen. This case demonstrates a potential complication of COVID-19 in a previously healthy patient. The patient contracted COVID-19 in March 2020 and endured a complicated course including intubation, multiple readmissions, and chronic abdominal pain. He is now awaiting a liver transplant. Our case portrays biliary damage as an additional possible complication of COVID-19 and the importance of imaging in its diagnosis.

Indexed as

Cholangitis, SclerosingCOVID-19Liver TransplantationHumansMaleCholangiopathyCOVID-19HepatobiliarySecondary sclerosing cholangitis

Identifiers

PMID34364072
PMCPMC8314797
OpenAlexW3186131291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.